Date & time
Wednesday, February 20, 2019
4 p.m. – 5 p.m.
It can be postulated without difficulty that cognitive function is directly related to brain health; likewise, that future brain health status is based both on its current condition as well as on the on-going effects of genetic and environmental factors. I will propose a mechanistic concept of brain health, operationalized via measurable proxies of major organ-level brain systems that support cognitive function, and demonstrated its applicability towards the prediction of cognitive decline in the context of aging and probable Alzheimer’s disease.
The purpose of this talk is to:
Dr. Duchesne holds the positions of: Associate Professor and Co-section Head of research with the Radiology and Nuclear Medicine Department in the Faculty of Medicine at Laval University; Fonds de recherche Québec – Santé Research Scholar at the CERVO Center of the Mental Health University Institute of Quebec; co-director of the CERVO neuroimaging unit; director of the CERVO neuroinformatics unit; co-director of the Quebec Consortium for the early Identification of Alzheimer’s disease; and director of the neuroimaging platform of the Canadian Consortium for Neurodegeneration and Aging. He is a co-founder and chief executive officer of True Positive Medical Devices Inc. since its inception in 2011.
© Concordia University